Adnexus Therapeutics

Adnexus Therapeutics Overview

Founded 2002
Status Acquired/​Merged
Employees 193
Latest Deal Type M&A
Latest Deal Amount $415M
Latest Deal Amount

Adnexus Therapeutics General Information


Developer of Adnectins biologics/medicines in the United States. The company's product candidates include Angiocept/CT-322, an anti-angiogenesis agent for treating cancer that blocks the VEGFR-2 pathway; and other Adnectin therapies for the treatment of oncology, immunology, and cardiovascular diseases.

Contact Information

Formerly Known As
Compound Therapeutics
Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 100 Beaver Street
  • Waltham, MA 02453
  • United States
+1 (781) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Adnexus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Oct-2007 $415M 000.00 00000 Completed Startup
6. IPO 21-Aug-2007 000.00 Cancelled Clinical Trials - Phase 2
5. Early Stage VC 07-Aug-2007 000.00 000.00 Completed Startup
4. Early Stage VC (Series B) 20-Jun-2006 0000 000.00 Completed Startup
3. Convertible Debt 24-May-2006 00.00 000.00 Completed Startup
2. Early Stage VC 28-Dec-2004 $15.6M $22.1M Completed Startup
1. Early Stage VC (Series A) 03-Apr-2003 $6.5M $6.5M Completed Startup

Adnexus Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Bruce Silver MD Medical Director
Cliff Bechtold Vice President, Strategic Operations

7 Former Executives

Adnexus Therapeutics Former Investors (8)

To view Adnexus Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Applied Genomic Technology Capital Fund Venture Capital Minority 000 0000 000000 0
Atlas Venture Venture Capital Minority 000 0000 000000 0
Flagship Pioneering Venture Capital Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
HBM Partners Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial